5-160569533-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_025153.3(ATP10B):c.3901G>A(p.Val1301Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000316 in 1,613,722 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_025153.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATP10B | NM_025153.3 | c.3901G>A | p.Val1301Ile | missense_variant | 25/26 | ENST00000327245.10 | NP_079429.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATP10B | ENST00000327245.10 | c.3901G>A | p.Val1301Ile | missense_variant | 25/26 | 1 | NM_025153.3 | ENSP00000313600 | P1 | |
ATP10B | ENST00000642502.1 | c.3817G>A | p.Val1273Ile | missense_variant | 20/21 | ENSP00000493802 |
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 152136Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000201 AC: 5AN: 248990Hom.: 0 AF XY: 0.0000296 AC XY: 4AN XY: 135060
GnomAD4 exome AF: 0.0000287 AC: 42AN: 1461586Hom.: 0 Cov.: 31 AF XY: 0.0000303 AC XY: 22AN XY: 727098
GnomAD4 genome AF: 0.0000592 AC: 9AN: 152136Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74298
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 29, 2022 | The c.3901G>A (p.V1301I) alteration is located in exon 25 (coding exon 21) of the ATP10B gene. This alteration results from a G to A substitution at nucleotide position 3901, causing the valine (V) at amino acid position 1301 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at